CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-18 | Rodgers Richard J Director | Grant or award | +41,551 | 413,543 | ||
| 2025-06-18 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +54,059 | 54,059 | ||
| 2025-06-18 | Parsey Merdad Director | Grant or award | +15,235 | 57,291 | ||
| 2025-06-18 | MOTT DAVID M Director | Grant or award | +31,163 | 2,928,034 | ||
| 2025-06-18 | MOTT DAVID M Director | Grant or award | +41,551 | 2,969,585 | ||
| 2025-06-18 | MOTT DAVID M Director | Grant or award · Stock Option (Right to Buy) | +54,059 | 54,059 | ||
| 2025-06-18 | Cadoret-Manier Onaiza Director | Grant or award | +41,551 | 151,701 | ||
| 2025-06-18 | Cadoret-Manier Onaiza Director | Grant or award · Stock Option (Right to Buy) | +54,059 | 54,059 | ||
| 2025-06-18 | Bhanji Muna Director | Grant or award | +41,551 | 137,353 | ||
| 2025-06-18 | Bhanji Muna Director | Grant or award · Stock Option (Right to Buy) | +54,059 | 54,059 | ||
| 2025-06-18 | Bertrand William C JR Director | Grant or award | +19,390 | 249,156 | ||
| 2025-06-18 | Bertrand William C JR Director | Grant or award | +41,551 | 290,707 | ||
| 2025-06-18 | Bertrand William C JR Director | Grant or award · Stock Option (Right to Buy) | +54,059 | 54,059 | ||
| 2025-06-16 | MOTT DAVID M Director | Purchase | +200,000 | $3.63 | $726K | 2,896,871 |
| 2025-06-09 | MOTT DAVID M Director | Purchase | +200,000 | $3.69 | $737K | 2,696,871 |
| 2025-05-20 | Williams Laura A Chief Medical Officer | Sale | −6,421 | $4.08 | $26K | 402,583 |
| 2025-05-20 | Renz Justin A Chief Financial Officer | Sale | −7,218 | $4.08 | $29K | 416,089 |
| 2025-05-20 | RAAB MICHAEL President & CEO | Sale | −46,817 | $4.08 | $191K | 1,547,937 |
| 2025-05-20 | Kelliher Mike See Remarks | Sale | −14,522 | $4.08 | $59K | 282,158 |
| 2025-05-20 | GRAMMER ELIZABETH A See Remarks | Sale | −5,992 | $4.08 | $24K | 311,731 |
Page 8 of 11 · 206 trades